Narender Annapureddy MD MS
Lupus & Related, Myositis, Osteoporosis & Bone Metabolism
Associate Professor of Medicine at Vanderbilt University Medical Center Fellowship Director, Rheumatology
Join to View Full Profile
1161 21st Ave SSte T3113Nashville, TN 37232
Phone+1 615-322-1900
Fax+1 615-936-0605
Dr. Annapureddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Rheumatology, 2012 - 2014
Rush UniversityMS, Clinical Research, 2012 - 2014
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2009 - 2012
Osmania Medical College NTR UHSClass of 2007
Certifications & Licensure
TN State Medical License 2014 - 2026
AL State Medical License 2020 - 2020
IL State Medical License 2012 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 3 citationsUsing pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned.Timothy Beukelman, Lang Chen, Narender Annapureddy, Jim Oates, Megan E B Clowse
Pharmacoepidemiology and Drug Safety. 2023-09-01 - 2 citationsDevelopment and Validation of an Emergency Department Electronic Medical Record Gout Flare Alert.Lesley E Jackson, Narender Annapureddy, Megan E Hansen, Kenneth G Saag, James Booth
Arthritis Care & Research. 2023-08-01 - 9 citationsCD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease.Erin M. Wilfong, Katherine N. Vowell, Kaitlyn E Bunn, Elise Rizzi, Narender Annapureddy
Clinical and Experimental Medicine. 2021-08-10
Press Mentions
Learn More About the 2023 EULAR Recommendations and What These May Mean for Your Patients with #Lupus. Listen to This PoSeptember 26th, 2024- Learn More About the 2023 EULAR Recommendations and What These May Mean for Your Patients with #Lupus. Listen to This PoSeptember 18th, 2024
- Learn More About the 2023 EULAR Recommendations and What These May Mean for Your Patients with #Lupus. Listen to This PoSeptember 12th, 2024
- Join now to see all
Professional Memberships
- Fellows-in-Training 3rd year
Other Languages
- Telugu, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
